Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1986-01

AUTHORS

Y. Ambroes, I. Ronflette, L. Dodion

ABSTRACT

Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

1-7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00541460

DOI

http://dx.doi.org/10.1007/bf00541460

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003363483

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3780835


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnesium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Torsemide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uric Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ambroes", 
        "givenName": "Y.", 
        "id": "sg:person.01242546465.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronflette", 
        "givenName": "I.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Department A. Christiaens S.A., Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dodion", 
        "givenName": "L.", 
        "id": "sg:person.01356775065.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0026-0495(73)90264-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008746933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197104152841506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010957021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(79)80338-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011589858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(80)90204-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013813794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00625798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029985014", 
          "https://doi.org/10.1007/bf00625798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.3.5827.620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031136057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1978.tb00837.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038315847"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(82)91506-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038590926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1980.03310150027023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044819086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.280.6218.905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048678221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(69)90187-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050813268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.244.15.1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054139508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1111261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057126788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1113442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057128956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078454423", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082160355", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1986-01", 
    "datePublishedReg": "1986-01-01", 
    "description": "Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00541460", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects", 
    "pagination": "1-7", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3780835"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00541460"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003363483"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00541460", 
      "https://app.dimensions.ai/details/publication/pub.1003363483"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130830_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00541460"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      64 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00541460 schema:about N166e63a1def54419af2926591fde05d3
2 N1c507989d7924553ade9cc332796b522
3 N3cc845b7dbef46dd8367fd4f6152a72e
4 N427c89d4e0284294b9c1cbb9b1a0ecfe
5 N4314fa48816a49c5b4592e44a8618c65
6 N4821afdf1f344e86974e6ab0c3e1ba74
7 N4f26ceb9a3de46eabe0c787f50baff50
8 N6ec90336386a41beaf951c27894cfd13
9 N8a15081fc7564b00bd382d9c3777800e
10 N91e86e3ded884e6db67836893f5baf2d
11 Na2fa679d3c1d4d35a787e0cbc6ed6807
12 Nbe0754f02ffe4a7aa088f59a9e62450e
13 Nd93eb4b3cd4340b48a4bc3ecc05bccb3
14 Ne809fdaf566f4f5fb82131193c956a36
15 Neae4c1b764cf413b82663362ff61704c
16 Nf50d88ae60af45db8f74e92d1fa87811
17 Nf5f98d05e1eb42bfa609ba72f9f8ab76
18 anzsrc-for:11
19 anzsrc-for:1116
20 schema:author Nb969731d380e473ca3afa8bcf7ccff04
21 schema:citation sg:pub.10.1007/bf00541465
22 sg:pub.10.1007/bf00625798
23 sg:pub.10.1007/bf01747104
24 https://app.dimensions.ai/details/publication/pub.1078454423
25 https://app.dimensions.ai/details/publication/pub.1082160355
26 https://doi.org/10.1001/jama.1980.03310150027023
27 https://doi.org/10.1001/jama.244.15.1691
28 https://doi.org/10.1016/0002-9343(69)90187-9
29 https://doi.org/10.1016/0021-9150(80)90204-x
30 https://doi.org/10.1016/0026-0495(73)90264-3
31 https://doi.org/10.1016/s0002-9149(79)80338-0
32 https://doi.org/10.1016/s0140-6736(82)91506-9
33 https://doi.org/10.1055/s-0028-1111261
34 https://doi.org/10.1055/s-0028-1113442
35 https://doi.org/10.1056/nejm197104152841506
36 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x
37 https://doi.org/10.1136/bmj.280.6218.905
38 https://doi.org/10.1136/bmj.3.5827.620
39 schema:datePublished 1986-01
40 schema:datePublishedReg 1986-01-01
41 schema:description Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N17de7dc9198447c8b7d0b8ae8b52795f
46 Nea620b03ebec451cba6ff2bd88921b32
47 sg:journal.1054337
48 schema:name Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects
49 schema:pagination 1-7
50 schema:productId N11b1b31fe0b044ffb7754aa7b7d5b07f
51 N476f87b2b409497dbec6b4dc13cb4f8e
52 Nb9cb3cf86b264b2abd5e3816ba573e9f
53 Nd2fc4394378f4775b4205fa0b93757f9
54 Ndd685639cf154ed78e2b3e22a64d3527
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003363483
56 https://doi.org/10.1007/bf00541460
57 schema:sdDatePublished 2019-04-11T14:01
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N66fd9133af9b435f818dd6187b1a89a1
60 schema:url http://link.springer.com/10.1007/BF00541460
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0a4218fe734a4f858d5cd78893015fa0 rdf:first Nab5297f16b0c4e3ea50e82aa09239f1c
65 rdf:rest Ne5413f1b15cc46138b55878ac33f68f2
66 N11b1b31fe0b044ffb7754aa7b7d5b07f schema:name doi
67 schema:value 10.1007/bf00541460
68 rdf:type schema:PropertyValue
69 N166e63a1def54419af2926591fde05d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Magnesium
71 rdf:type schema:DefinedTerm
72 N17de7dc9198447c8b7d0b8ae8b52795f schema:issueNumber Suppl 1
73 rdf:type schema:PublicationIssue
74 N1c507989d7924553ade9cc332796b522 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Uric Acid
76 rdf:type schema:DefinedTerm
77 N3cc845b7dbef46dd8367fd4f6152a72e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Diuretics
79 rdf:type schema:DefinedTerm
80 N40ead4503a04473cb76937e4478c2bb4 schema:name Saint Etienne Clinic, Brussels, Belgium
81 rdf:type schema:Organization
82 N427c89d4e0284294b9c1cbb9b1a0ecfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Torsemide
84 rdf:type schema:DefinedTerm
85 N4314fa48816a49c5b4592e44a8618c65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Humans
87 rdf:type schema:DefinedTerm
88 N476f87b2b409497dbec6b4dc13cb4f8e schema:name dimensions_id
89 schema:value pub.1003363483
90 rdf:type schema:PropertyValue
91 N4821afdf1f344e86974e6ab0c3e1ba74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Kinetics
93 rdf:type schema:DefinedTerm
94 N4f26ceb9a3de46eabe0c787f50baff50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Sulfonamides
96 rdf:type schema:DefinedTerm
97 N66fd9133af9b435f818dd6187b1a89a1 schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N6ec90336386a41beaf951c27894cfd13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Time Factors
101 rdf:type schema:DefinedTerm
102 N86d40e5f247f4e43a9cd99397181fc57 schema:name Saint Etienne Clinic, Brussels, Belgium
103 rdf:type schema:Organization
104 N8a15081fc7564b00bd382d9c3777800e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Male
106 rdf:type schema:DefinedTerm
107 N91e86e3ded884e6db67836893f5baf2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Urine
109 rdf:type schema:DefinedTerm
110 Na2fa679d3c1d4d35a787e0cbc6ed6807 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Sodium
112 rdf:type schema:DefinedTerm
113 Nab5297f16b0c4e3ea50e82aa09239f1c schema:affiliation N86d40e5f247f4e43a9cd99397181fc57
114 schema:familyName Ronflette
115 schema:givenName I.
116 rdf:type schema:Person
117 Nb969731d380e473ca3afa8bcf7ccff04 rdf:first sg:person.01242546465.34
118 rdf:rest N0a4218fe734a4f858d5cd78893015fa0
119 Nb9cb3cf86b264b2abd5e3816ba573e9f schema:name pubmed_id
120 schema:value 3780835
121 rdf:type schema:PropertyValue
122 Nbe0754f02ffe4a7aa088f59a9e62450e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Potassium
124 rdf:type schema:DefinedTerm
125 Ncc82ad9981c94e11b3e21ca7545f8389 schema:name Medical Department A. Christiaens S.A., Brussels, Belgium
126 rdf:type schema:Organization
127 Nd2fc4394378f4775b4205fa0b93757f9 schema:name readcube_id
128 schema:value 1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c
129 rdf:type schema:PropertyValue
130 Nd93eb4b3cd4340b48a4bc3ecc05bccb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Lipids
132 rdf:type schema:DefinedTerm
133 Ndd685639cf154ed78e2b3e22a64d3527 schema:name nlm_unique_id
134 schema:value 1256165
135 rdf:type schema:PropertyValue
136 Ne5413f1b15cc46138b55878ac33f68f2 rdf:first sg:person.01356775065.07
137 rdf:rest rdf:nil
138 Ne809fdaf566f4f5fb82131193c956a36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Female
140 rdf:type schema:DefinedTerm
141 Nea620b03ebec451cba6ff2bd88921b32 schema:volumeNumber 31
142 rdf:type schema:PublicationVolume
143 Neae4c1b764cf413b82663362ff61704c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Blood Glucose
145 rdf:type schema:DefinedTerm
146 Nf50d88ae60af45db8f74e92d1fa87811 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Adult
148 rdf:type schema:DefinedTerm
149 Nf5f98d05e1eb42bfa609ba72f9f8ab76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Calcium
151 rdf:type schema:DefinedTerm
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical Physiology
157 rdf:type schema:DefinedTerm
158 sg:journal.1054337 schema:issn 0031-6970
159 1432-1041
160 schema:name European Journal of Clinical Pharmacology
161 rdf:type schema:Periodical
162 sg:person.01242546465.34 schema:affiliation N40ead4503a04473cb76937e4478c2bb4
163 schema:familyName Ambroes
164 schema:givenName Y.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34
166 rdf:type schema:Person
167 sg:person.01356775065.07 schema:affiliation Ncc82ad9981c94e11b3e21ca7545f8389
168 schema:familyName Dodion
169 schema:givenName L.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07
171 rdf:type schema:Person
172 sg:pub.10.1007/bf00541465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022122500
173 https://doi.org/10.1007/bf00541465
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/bf00625798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029985014
176 https://doi.org/10.1007/bf00625798
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/bf01747104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002452921
179 https://doi.org/10.1007/bf01747104
180 rdf:type schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1078454423 schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1082160355 schema:CreativeWork
183 https://doi.org/10.1001/jama.1980.03310150027023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044819086
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1001/jama.244.15.1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054139508
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/0002-9343(69)90187-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050813268
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0021-9150(80)90204-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013813794
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/0026-0495(73)90264-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008746933
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0002-9149(79)80338-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011589858
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s0140-6736(82)91506-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038590926
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1055/s-0028-1111261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057126788
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1055/s-0028-1113442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057128956
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1056/nejm197104152841506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010957021
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038315847
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1136/bmj.280.6218.905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048678221
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1136/bmj.3.5827.620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031136057
208 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...